| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |